Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

STAR: A Simple TAL Effector Assembly Reaction Using Isothermal Assembly.

Gogolok S, Köber U, Pollard SM.

Methods Mol Biol. 2018;1772:477-490. doi: 10.1007/978-1-4939-7795-6_29.

PMID:
29754248
2.

Distinct SoxB1 networks are required for naïve and primed pluripotency.

Corsinotti A, Wong FC, Tatar T, Szczerbinska I, Halbritter F, Colby D, Gogolok S, Pantier R, Liggat K, Mirfazeli ES, Hall-Ponsele E, Mullin NP, Wilson V, Chambers I.

Elife. 2017 Dec 19;6. pii: e27746. doi: 10.7554/eLife.27746.

3.

Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators.

Bulstrode H, Johnstone E, Marques-Torrejon MA, Ferguson KM, Bressan RB, Blin C, Grant V, Gogolok S, Gangoso E, Gagrica S, Ender C, Fotaki V, Sproul D, Bertone P, Pollard SM.

Genes Dev. 2017 Apr 15;31(8):757-773. doi: 10.1101/gad.293027.116. Epub 2017 May 2.

4.

Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells.

Bressan RB, Dewari PS, Kalantzaki M, Gangoso E, Matjusaitis M, Garcia-Diaz C, Blin C, Grant V, Bulstrode H, Gogolok S, Skarnes WC, Pollard SM.

Development. 2017 Feb 15;144(4):635-648. doi: 10.1242/dev.140855. Epub 2017 Jan 17.

5.

STAR: a simple TAL effector assembly reaction using isothermal assembly.

Gogolok S, Garcia-Diaz C, Pollard SM.

Sci Rep. 2016 Sep 12;6:33209. doi: 10.1038/srep33209.

6.

A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1.

Danovi D, Folarin A, Gogolok S, Ender C, Elbatsh AM, Engström PG, Stricker SH, Gagrica S, Georgian A, Yu D, U KP, Harvey KJ, Ferretti P, Paddison PJ, Preston JE, Abbott NJ, Bertone P, Smith A, Pollard SM.

PLoS One. 2013 Oct 30;8(10):e77053. doi: 10.1371/journal.pone.0077053. eCollection 2013.

7.

Anticancer effects of niclosamide in human glioblastoma.

Wieland A, Trageser D, Gogolok S, Reinartz R, Höfer H, Keller M, Leinhaas A, Schelle R, Normann S, Klaas L, Waha A, Koch P, Fimmers R, Pietsch T, Yachnis AT, Pincus DW, Steindler DA, Brüstle O, Simon M, Glas M, Scheffler B.

Clin Cancer Res. 2013 Aug 1;19(15):4124-36. doi: 10.1158/1078-0432.CCR-12-2895.

Supplemental Content

Loading ...
Support Center